FY2023
Global Cancer Advancements in Immunotherapy Research
See how CRI is transforming the lives of cancer patients on a global scale.
Want to learn more?
We invite you to download the following educational resources.

Get the Infographic
Explore in-depth insights, at a glance.

Get the Impact Report
Access FY2023 highlights and accomplishments.

$515M
invested in CRI scientists worldwide since 1953
$28.7M
invested in research grants and fellowships in FY2023
12
new FDA approvals

02 / Cancers
Redefining Immunotherapy Success
CRI scientists are accelerating discovery thanks to new technologies that marry data science, bioinformatics, and cancer immunology. To date, there are 4M patients eligible for immunotherapy treatments worldwide.

28
cancers now treatable with immunotherapy thanks to the work of CRI
Make your impact on cancer research


Make your impact on cancer research

05 / Discovery
Unleashing Science with the Power of Data
CRI funded a clinical trial spearheaded by Dr. Valsamo “Elsa” Anagnostou, MD, PhD, from Johns Hopkins, investigating ctDNA technology’s potential. This method, through a blood draw, provides valuable insights into tumor genetics and activity. The trial showed that ctDNA analysis yielded faster, more accurate responses and enhanced predictions for long-term patient outcomes.


Our Mission
Save more lives by fueling the discovery and development of powerful immunotherapies for all cancers.
This year, CRI proudly celebrates funding 70 years of discovery in cancer immunotherapy. As a top-tier nonprofit that upholds fiscal integrity and transparency, CRI ensures every donation fuels impactful cancer immunotherapy research. Ranked among the top 5% of U.S. charities, we’re dedicated to saving lives worldwide.